Current Report Filing (8-k)
15 November 2022 - 01:06AM
Edgar (US Regulatory)
0001872356 false 0001872356 2022-11-14
2022-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 14, 2022
AeroClean Technologies, Inc.
|
(Exact
name of registrant as specified in its charter) |
Delaware |
|
001-41096 |
|
45-3213164 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
10455 Riverside Dr. |
|
|
Palm Beach Gardens,
FL |
|
33410 |
(Address of principal executive offices) |
|
(Zip
Code) |
Registrant’s telephone number, including area code:
833-652-5326
N/A |
(Former
name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
x |
Written
communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425) |
¨ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12) |
¨ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e 4(c)) |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
x
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the
Act:
Title
of each class |
|
Ticker
symbol(s) |
|
Name
of each exchange on which registered |
Common stock |
|
AERC |
|
The
Nasdaq Stock Market LLC |
Item 2.02. |
Results of Operations and Financial
Condition. |
On November 14, 2022, AeroClean Technologies, Inc. (the “Company”)
issued a press release announcing its financial results for the
third quarter ended September 30, 2022.
The press release is included as Exhibit 99.1 hereto. The
information furnished under this Item 2.02, including the exhibit
related thereto, shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, nor
shall it be deemed incorporated by reference in any disclosure
document of the Company, except as shall be expressly set forth by
specific reference in such document.
Important Additional Information
This Current Report on Form 8-K relates to a proposed business
combination between AeroClean and Molekule (the “Business
Combination”). In connection with the proposed Business
Combination, AeroClean intends to file a registration statement on
Form S-4 (the “Registration Statement”) that will include an
information statement relating to the proposed Business Combination
(the “Information Statement”) that will be sent to AeroClean’s
stockholders. The Registration Statement and Information
Statement will contain important information about AeroClean,
Molekule, the Business Combination and related matters
(collectively, the “Transactions”). STOCKHOLDERS ARE URGED TO
CAREFULLY READ THE ENTIRE REGISTRATION STATEMENT AND INFORMATION
STATEMENT AND OTHER RELEVANT DOCUMENTS FILED WITH THE SECURITIES
AND EXCHANGE COMMISSION (THE “SEC”) WHEN THEY BECOME AVAILABLE,
BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. The Information
Statement will be sent to AeroClean’s stockholders prior to the
consummation of the Transactions. AeroClean stockholders will be
able to obtain the Registration Statement and Information Statement
from the SEC’s website or from AeroClean’s website. These documents
may also be obtained free of charge from AeroClean by requesting
them by mail at 10455 Riverside Drive, Suite 100, Palm Beach
Gardens, FL 33410.
No Offer or Solicitation
This Current Report on Form 8-K shall not constitute an offer to
sell or the solicitation of an offer to sell or the solicitation of
an offer to buy any securities, nor shall there be any sale of
securities in any jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under
the securities laws of any such jurisdiction. No offer of
securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act of 1933,
as amended, and otherwise in accordance with applicable law.
Forward-Looking Statements
This Current Report on Form 8-K contains “forward-looking
statements” within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based upon current beliefs and
expectations of our management and are subject to known and unknown
risks and uncertainties. Words or expressions such as “expects,”
“anticipates,” “intends,” “plans,” “believes,” “estimates,” “may,”
“will,” “projects,” “could,” “should,” “would,” “seek,” “forecast,”
or other similar expressions help identify forward-looking
statements. Factors that could cause actual events to differ
include, but are not limited to:
|
· |
the risk that the Transactions may not be completed; |
|
· |
the ability to successfully combine the businesses of AeroClean
and Molekule; |
|
· |
the ability of the parties to achieve the expected synergies
and other benefits from the Transactions within the expected time
frames or at all; |
|
· |
the incurrence of significant transaction and other related
fees and costs; |
|
· |
the incurrence of unexpected costs, liabilities or delays
relating to the Transactions; |
|
· |
the risk that the public assigns a lower value to
Molekule’s business
than the value used in negotiating the terms of the
Transactions; |
|
· |
the risk that the Transactions may not be accretive to
AeroClean’s current
stockholders; |
|
· |
the risk that the Transactions may prevent AeroClean from
acting on future opportunities to enhance stockholder value; |
|
· |
the dilutive impact of the stock consideration which will be
issued in the Transactions; |
|
· |
the risk that any goodwill or identifiable intangible assets
recorded due to the Transactions could become impaired; |
|
· |
potential disruptions to the business of the companies while
the Transactions are pending; |
|
· |
the risk that a closing condition to the Transactions may not
be satisfied; |
|
· |
the occurrence of any event, change or other circumstances that
could give rise to the termination of the Transactions; and |
|
· |
other economic, business,
competitive, and regulatory factors affecting the businesses of
AeroClean and Molekule generally, including those set forth in
AeroClean’s filings with
the SEC, including in the “Risk
Factors” and
“Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” sections of AeroClean’s latest annual report on Form
10-K, quarterly reports on Form 10-Q, current reports on Form 8-K,
and other SEC filings. |
Forward looking statements are not guarantees of future performance
and involve risks and uncertainties, and actual results may differ
materially from those in the forward looking statements as a result
of various factors. Although AeroClean believes that the
expectations reflected in the forward looking statements are
reasonable based on information currently available, AeroClean
cannot assure you that the expectations will prove to have been
correct. Accordingly, you should not place undue reliance on these
forward looking statements. In any event, these statements speak
only as of the date of this release. The parties undertake no
obligation to revise or update any of the forward looking
statements to reflect events or circumstances after the date of
this release or to reflect new information or the occurrence of
unanticipated events.
Item 9.01. |
Financial Statements and
Exhibits. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Dated: November 14, 2022 |
AEROCLEAN
TECHNOLOGIES, INC. |
|
By: |
/s/ Jason DiBona |
|
|
Name: Jason DiBona |
|
|
Title: Chief Executive
Officer |
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From May 2023 to Jun 2023
AeroClean Technologies (NASDAQ:AERC)
Historical Stock Chart
From Jun 2022 to Jun 2023